ArticleBiochemical genetics2026
Early Detection of Sex and Cannabinoid Chemotypes in Cannabis sativa: SCAR Marker Validation in Indigenous Indian Germplasm.
Article in Biochemical genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cannabis sativa is a versatile crop of immense industrial and medicinal value, cultivated for its fiber, seeds, and especially for its bioactive cannabinoids, yet early identification of sex and chemotype remains challenging due to delayed morphological differentiation and limited cannabinoid accumulation during early growth. This study validated reproducible DNA markers for early selection in Indian cannabis germplasm. For sex determination, i.e., three Sequence Characterized Amplified Region (SCAR) markers-SCAR119, SCAR323, and the Male-Associated DNA Clone 2 (MADC2), were evaluated. The MADC2 marker reliably amplified a 390 bp fragment in male plants, whereas most female plants exhibited 560 bp and 870 bp bands. This strong correlation between MADC2 genotypes and phenotypic sex underscores its utility for early sex identification, which is critical for maximizing cannabinoid yield by preventing unwanted pollination. In parallel, chemotype-specific markers were assessed to predict cannabinoid profiles. Using high-performance liquid chromatography (HPLC), plants were classified into three chemotypes based on THCA: CBDA ratios: THC-dominant, intermediate, and CBD-dominant. The dominant marker D589 was associated with THC biosynthesis, while the co-dominant marker B1080/B1192 provided refined differentiation between chemotypes by detecting allelic variations in cannabinoid synthase genes. Cloning and sequence analysis of these markers revealed significant similarity to known genomic regions involved in cannabinoid production. In summary, the validated SCAR markers enable early and accurate identification of sex and cannabinoid chemotype in Cannabis sativa. These tools offer substantial benefits for marker-assisted breeding, regulatory compliance (e.g., maintaining THC levels below 0.3% for hemp), and optimizing cultivation practices for both industrial and pharmaceutical applications in India.
Indexed as
Identifiers
40536695What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.